Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy

被引：0
|
作者：
Mari Yokoi
Daiki Tsuji
Kenichi Suzuki
Yohei Kawasaki
Masahiko Nakao
Hideaki Ayuhara
Yuuki Kogure
Kazuhiko Shibata
Toshinobu Hayashi
Keita Hirai
Kazuyuki Inoue
Toshihiro Hama
Koji Takeda
Makoto Nishio
Kunihiko Itoh
机构：
[1] University of Shizuoka,Department of Clinical Pharmacology & Genetics, School of Pharmaceutical Sciences
[2] Cancer Institute Hospital,Department of Pharmacy, Japanese Foundation for Cancer Research
[3] University of Shizuoka,Department of Drug Evaluation and Informatics, School of Pharmaceutical Sciences
[4] Osaka City General Hospital,Department of Pharmacy
[5] Tokyo Medical University Hospital,Department of Pharmacy
[6] National Hospital Organization Shikoku Cancer Center,Department of Pharmacy
[7] Kouseiren Takaoka Hospital,Department of Medical Oncology
[8] National Hospital Organization Kyushu Medical Center,Department of Pharmacy
[9] Osaka City General Hospital,Department of Clinical Oncology
[10] Cancer Institute Hospital,Department of Thoracic Medical Oncology, Japanese Foundation for Cancer Research
来源：
Supportive Care in Cancer | 2018年 / 26卷
关键词：
Chemotherapy-induced nausea and vomiting (CINV); polymorphism; Cisplatin; Granisetron; Palonosetron; Aprepitant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1505 / 1513
页数：8
相关论文
共 50 条
  • [31] Prospective evaluation for chemotherapy-induced nausea and vomiting in colorectal cancer receiving oxaliplatin-based chemotherapy of moderate emetic risk
    Shimokawa, M.
    Hayashi, T.
    Kogawa, T.
    Matsui, R.
    Suzuki, K.
    Saeki, T.
    Aiba, K.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2016, 27 : 17 - 17
  • [32] THE CONTROL OF CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
    DODDS, LJ
    JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1985, 10 (02): : 143 - 166
  • [33] Chemotherapy-induced nausea and vomiting
    Lohr, Lisa
    CANCER JOURNAL, 2008, 14 (02): : 85 - 93
  • [34] Efficacy of 3-day versus 5-day aprepitant regimens for long-delayed chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy
    Hayashi, Toshinobu
    Shimokawa, Mototsugu
    Matsuo, Koichi
    Kawada, Kei
    Nakano, Takafumi
    Egawa, Takashi
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2221 - 2226
  • [35] Rolapitant for the prevention of chemotherapy-induced nausea and vomiting in breast cancer patients receiving multiple cycles of emetogenic chemotherapy
    Schwartzberg, L.
    Navari, R.
    Arora, S.
    Powers, D.
    Jordan, K.
    Rapoport, B.
    CANCER RESEARCH, 2017, 77
  • [36] Prevention of chemotherapy-induced nausea and vomiting in elderly cancer patients
    Jakobsen, Jan Nyrop
    Herrstedt, Jorn
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 71 (03) : 214 - 221
  • [37] Effect of Ginger on Chemotherapy-Induced Nausea and/or Vomiting in Cancer Patients
    Alparslan, Gueler Balci
    Ozkarman, Ayse
    Eskin, Nuran
    Yilmaz, Songuel
    Akay, Meltem
    Acikgoz, Ayfer
    Orsal, Ozlem
    JOURNAL OF THE AUSTRALIAN TRADITIONAL-MEDICINE SOCIETY, 2012, 18 (01): : 15 - 18
  • [38] Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients
    Janelsins, Michelle C.
    Tejani, Mohamedtaki A.
    Kamen, Charles
    Peoples, Anita R.
    Mustian, Karen M.
    Morrow, Gary R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (06) : 757 - 766
  • [39] The Relationship of Resilience and Chemotherapy-induced Nausea and Vomiting in Cancer Patients
    Chang, Qing
    PSYCHO-ONCOLOGY, 2015, 24 : 234 - 234
  • [40] Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer
    Navari, Rudolph M.
    FUTURE ONCOLOGY, 2010, 6 (07) : 1073 - 1084
12345